TotalMarketCap

Lakewood-Amedex Biotherapeutics

LABTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.422 M

$0.60 +213.48%

Close of 6 Nov 2026

As of 6 Nov 2026, Lakewood-Amedex Biotherapeutics (LABT) has a market capitalization of $1.42M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$3.85M

Loss-making

Shares outstanding

2,369,688

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #489OragenicsOGEN$1.55M
  2. #490Kairos PharmaKAPA$1.55M
  3. #491Lakewood-Amedex BiotherapeuticsLABT$1.42M
  4. #492Karyopharm TherapeuticsKPTI$1.40M
  5. #493PMGCELAB$1.32M

What if Lakewood-Amedex Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$11,915,860

Per share 19,859,766× higher

Bitcoin $1.53T

$644,746.42

Per share 1,074,577× higher

Apple $5.02T

$2,116,642

Per share 3,527,737× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Lakewood-Amedex Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.